{
  "id": 3578,
  "text": "1564.Meanwell, C.A., et al.Phase II study of ifosfamide in cervical cancer.Cancer Treat Rep 70, 727-730 (1986).1565.Sutton, G.P., Blessing, J.A., DiSaia, P.J.& McGuire, W.P.Phase II study of ifosfamide and mesna in nonsquamous carcinoma of the cervix: a Gynecologic Oncology Group study.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: 1564.Meanwell, C.A., et al.Phase II study of ifosfamide in cervical cancer.Cancer Treat Rep 70, 727-730 (1986).1565.Sutton, G.P., Blessing, J.A., DiSaia, P.J.& McGuire, W.P.Phase II study of ifosfamide and mesna in nonsquamous carcinoma of the cervix: a Gynecologic Oncology Group study.\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "基于相关研究，异福尔酰胺（Ifosfamide）联用美司钠（Mesna）是二期临床试验中可能用于治疗非鳞状细胞型宫颈癌的一种药物组合。这种治疗方案旨在提高疗效，同时利用美司钠减少异福尔酰胺引起的膀胱毒性。这些药物的应用被认为在化疗中具有潜在的价值，尤其是在灵活应对非鳞状细胞型宫颈癌患者时。",
  "query": "如果非鳞状细胞型的宫颈癌患者正在接受化疗，有哪些药物可能会用于二期临床试验研究中？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 如果非鳞状细胞型的宫颈癌患者正在接受化疗，有哪些药物可能会用于二期临床试验研究中？\n\n<reference text>: 1564.Meanwell, C.A., et al.Phase II study of ifosfamide in cervical cancer.Cancer Treat Rep 70, 727-730 (1986).1565.Sutton, G.P., Blessing, J.A., DiSaia, P.J.& McGuire, W.P.Phase II study of ifosfamide and mesna in nonsquamous carcinoma of the cervix: a Gynecologic Oncology Group study.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "基于相关研究，异福尔酰胺（Ifosfamide）联用美司钠（Mesna）是二期临床试验中可能用于治疗非鳞状细胞型宫颈癌的一种药物组合。这种治疗方案旨在提高疗效，同时利用美司钠减少异福尔酰胺引起的膀胱毒性。这些药物的应用被认为在化疗中具有潜在的价值，尤其是在灵活应对非鳞状细胞型宫颈癌患者时。"
}